MaxCyte, Inc.
At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients' lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today's processes to innovate tomorrow's solutions. Our ExPERT™ platform, which is based on our Flow Electroporation technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: three instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology, as well as technical and regulatory support, we aim to guide them on their journey to transform human health. Our Vision: Together, we maximize the potential of cells to improve lives. Our Mission: We build trust with our customers, and together we leverage best-in-class technology and expertise to solve the toughest challenges in cell engineering, bringing therapies to patients. Our Core Values: - We value and respect each other, our partners, and patients - We remain undaunted in our commitment to relieving the burden of disease - We dig deep, working together to understand the problem, and always find a way - We stay curious and connected, and never get complacent - We approach each person, each situation with compassion and transparency - We take pride in the excellence of our technology and the expertise we deliver
- website: http://www.maxcyte.com
- facebook: facebook.com/maxcyte
- twitter: https://twitter.com/MaxCyte_info
- linkedin: http://www.linkedin.com/company/maxcyte-inc-
- angellist: http://angel.co/maxcyte